Colin Shannon, President & CEO at PRA Health Sciences, Inc. (PRAH), sold 664,287 shares at $166.89 ($112.1M) on 2021-06-17, disclosed to the SEC on 2021-06-21.
Open-market sale of $112.1M PRAH by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $166.89 | 920 | $154K | 0.1% |
| 2 | $166.89 | 920 | $154K | 0.1% |
| 3 | $168.13 | 161,352 | $27.1M | 24.2% |
| 4 | $168.13 | 161,352 | $27.1M | 24.2% |
| 5 | $169.00 | 220,195 | $37.2M | 33.2% |
| 6 | $169.63 | 59,774 |
| $10.1M |
| 9.0% |
| 7 | $169.63 | 59,774 | $10.1M | 9.0% |
| Total | $168.68 avg | 664,287 | $112.1M | 100% |
| Filing → |
| PRAH | SELL | 2021-06-03 | $2.2M | — | Filing → |
| PRAH | SELL | 2020-08-17 | $1.2M | — | Filing → |
| PRAH | SELL | 2017-08-16 | $59.9M | — | Filing → |